Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
4.425
-0.385 (-8.00%)
Mar 31, 2025, 1:39 PM EDT - Market open

Y-mAbs Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Revenue
87.6984.8265.2734.920.75
Upgrade
Revenue Growth (YoY)
3.38%29.96%87.03%68.18%-
Upgrade
Cost of Revenue
15.2511.427.572.512.2
Upgrade
Gross Profit
72.4373.457.732.3818.55
Upgrade
Selling, General & Admin
50.1344.552.4756.9445.9
Upgrade
Research & Development
47.4150.0988.5590.8892.58
Upgrade
Operating Expenses
97.5494.59141.02147.82138.48
Upgrade
Operating Income
-25.11-21.19-83.32-115.43-119.94
Upgrade
Interest Expense
----1.85-
Upgrade
Interest & Investment Income
3.434.280.64-0.02
Upgrade
Currency Exchange Gain (Loss)
-2.040.52--0.58
Upgrade
EBT Excluding Unusual Items
-23.72-16.38-82.68-117.29-119.34
Upgrade
Merger & Restructuring Charges
-1.52-4.48---
Upgrade
Gain (Loss) on Sale of Assets
---62.01-
Upgrade
Asset Writedown
---0.62--
Upgrade
Legal Settlements
-3.85----
Upgrade
Other Unusual Items
-0.72--12.28--
Upgrade
Pretax Income
-29.81-20.87-95.57-55.28-119.34
Upgrade
Income Tax Expense
-0.150.56---
Upgrade
Net Income
-29.67-21.43-95.57-55.28-119.34
Upgrade
Net Income to Common
-29.67-21.43-95.57-55.28-119.34
Upgrade
Shares Outstanding (Basic)
4444444340
Upgrade
Shares Outstanding (Diluted)
4444444340
Upgrade
Shares Change (YoY)
1.57%-0.13%1.21%7.64%14.03%
Upgrade
EPS (Basic)
-0.67-0.49-2.19-1.28-2.97
Upgrade
EPS (Diluted)
-0.67-0.49-2.19-1.28-2.97
Upgrade
Free Cash Flow
-15.71-27.23-75.92-103.22-91.41
Upgrade
Free Cash Flow Per Share
-0.35-0.62-1.74-2.39-2.28
Upgrade
Gross Margin
82.61%86.54%88.41%92.80%89.38%
Upgrade
Operating Margin
-28.64%-24.98%-127.66%-330.78%-578.00%
Upgrade
Profit Margin
-33.83%-25.26%-146.43%-158.40%-575.12%
Upgrade
Free Cash Flow Margin
-17.92%-32.11%-116.32%-295.79%-440.51%
Upgrade
EBITDA
-24.58-20.46-82.48-114.65-119.54
Upgrade
EBITDA Margin
-28.03%-24.12%-126.37%--
Upgrade
D&A For EBITDA
0.540.740.840.780.4
Upgrade
EBIT
-25.11-21.19-83.32-115.43-119.94
Upgrade
EBIT Margin
-28.64%-24.98%-127.66%--
Upgrade
Revenue as Reported
87.6984.8265.2734.920.75
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q